Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

27.49
-0.2950-1.06%
Volume:16.48M
Turnover:453.40M
Market Cap:156.27B
PE:36.17
High:27.75
Open:27.75
Low:27.40
Close:27.78
52wk High:29.21
52wk Low:23.58
Shares:5.69B
Float Shares:5.64B
Volume Ratio:0.70
T/O Rate:0.29%
Dividend:1.72
Dividend Rate:6.26%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.83
PE(LYR):20.14

Loading ...

Pfizer is Maintained at Buy by Guggenheim

Dow Jones
·
Aug 08

Pfizer and BioNTech Advance Variant-Adapted COVID-19 Booster in New Phase 4 Study

TIPRANKS
·
Aug 08

Analysts’ Opinions Are Mixed on These Healthcare Stocks: NRX Pharmaceuticals (NRXP), Novo Nordisk (NVO) and Pfizer (PFE)

TIPRANKS
·
Aug 08

Guggenheim Adjusts Price Target on Pfizer to $31 From $35, Maintains Buy Rating

MT Newswires Live
·
Aug 07

Top Pfizer Executive Quietly Cashes Out in Notable Insider Stock Move

TIPRANKS
·
Aug 07

NYSE Most Active Issues

Dow Jones
·
Aug 07

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Sight Sciences (SGHT)

TIPRANKS
·
Aug 07

Pfizer Completes Key Early Study on PF-07328948, Sharpening Its Long-Term Pipeline Story

TIPRANKS
·
Aug 07

Pfizer and BioNTech Lock In Next-Gen Pediatric COVID Booster Edge

TIPRANKS
·
Aug 07

Pfizer SVP, Controller Jennifer B. Damico Sells 3,278 Shares Worth $83,261.2

Reuters
·
Aug 06

Pfizer Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 06

Pfizer Director Mortimer J. Buckley Reports Purchase of 37,632 Shares Worth $960,368.64

Reuters
·
Aug 06

Rothschild & Co Redburn Adjusts Pfizer Price Target to $25 From $24, Maintains Neutral Rating

MT Newswires Live
·
Aug 05

Pfizer Posts Transcript of Q2 2026 Earnings Call

Reuters
·
Aug 05

Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (PFE), Exagen (XGN) and Warby Parker (WRBY)

TIPRANKS
·
Aug 05

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Lipocine (LPCN) and High Tide (HITI)

TIPRANKS
·
Aug 05

Street View: Growth Drugs Lift Pfizer Outlook, but Execution Remains Key

Reuters
·
Aug 05

Pfizer beats earnings estimates, targets US$2.5 billion in additional cost cuts

Bloomberg
·
Aug 05

RBC Capital Remains a Hold on Pfizer (PFE)

TIPRANKS
·
Aug 05

Pfizer: Hold Rating Reaffirmed as COVID Headwinds Persist and 12‑Month Price Target Remains Unchanged at $26

TIPRANKS
·
Aug 05